Altrakincept

N/A

Report date: 2023/04/25 14:17:06

Base Information

Drug NameAltrakincept

Drug Alias NameIL-4 receptorinterleukin-4 receptorIL-4R (Immunex)Nuvance

ClassificationBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionInterleukin-4 receptor subunit alpha modulators

TargetsInterleukin-4 receptor subunit alpha

Therapy Area/IndicationsAsthma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAmgen Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAmgen Inc

Active IndicationsN/A

Inactive IndicationsAsthma

ATC CodeN/A